- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 164.45M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 165.12M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 163.69M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 159.8M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 160.71M sh |
| Capex | Q3 2025 · Sep 27, 2025 | $167.38M |
| Capex | Q3 2025 · Sep 28, 2024 | $219.31M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2025 | $234.75M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2024 | $208.51M |
| Long Term Debt | Q3 2025 · Sep 27, 2025 | $1.94B |
| Long Term Debt | Q3 2025 · Dec 28, 2024 | $2.66B |
| Short Term Debt | Q3 2025 · Sep 27, 2025 | $277.77M |
| Short Term Debt | Q3 2025 · Dec 28, 2024 | $32.23M |
| Cash And Equivalents | Q3 2025 · Sep 27, 2025 | $162.03M |
| Cash And Equivalents | Q3 2025 · Dec 28, 2024 | $149.57M |
| Stockholders Equity | Q3 2025 · Sep 27, 2025 | $793.49M |
| Stockholders Equity | Q3 2025 · Dec 28, 2024 | $607.33M |
| Current Liabilities | Q3 2025 · Sep 27, 2025 | $648.15M |
| Current Liabilities | Q3 2025 · Dec 28, 2024 | $433.9M |
| Total Liabilities | Q3 2025 · Sep 27, 2025 | $3.36B |
| Total Liabilities | Q3 2025 · Dec 28, 2024 | $4.65B |
| Current Assets | Q3 2025 · Sep 27, 2025 | $585.13M |
| Current Assets | Q3 2025 · Dec 28, 2024 | $657.44M |
| Total Assets | Q3 2025 · Sep 27, 2025 | $4.15B |
| Total Assets | Q3 2025 · Dec 28, 2024 | $5.26B |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $0.37 |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $0.69 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | −$0.09 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $0.12 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $0.37 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $0.69 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | −$0.09 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $0.12 |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $145.18M |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $471.35M |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $149.79M |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $393.42M |
| Operating Income | Q3 2025 · Sep 27, 2025 | $61.94M |
| Operating Income | Q3 2025 · Sep 27, 2025 | $161.31M |
| Operating Income restated | Q3 2025 · Sep 28, 2024 | $49.64M |
| Operating Income restated | Q3 2025 · Sep 28, 2024 | $207.79M |
| Revenue | Q3 2025 · Sep 27, 2025 | $535.68M |
| Revenue | Q3 2025 · Sep 27, 2025 | $1.6B |
| Revenue restated | Q3 2025 · Sep 28, 2024 | $502.34M |
| Revenue restated | Q3 2025 · Sep 28, 2024 | $1.5B |